TVTX short interest
Travere Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 12,655,839 |
|---|---|
| Change vs prior report | -300,094 (-2.3%) |
| Change over six months | -5.9% |
| Days to cover | 7.23 (sector: 3.78) |
| Average daily volume | 1,751,519 |
| Rank in Healthcare | #234 of 922 by days to cover |
TVTX short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 12,655,839 | -2.3% | 7.23 | 1,751,519 |
| 2026-09-15 | 12,955,933 | +7.9% | 10.38 | 1,247,781 |
| 2026-08-31 | 12,004,820 | +0.5% | 9.56 | 1,256,259 |
| 2026-08-14 | 11,943,638 | +2.3% | 5.70 | 2,095,016 |
| 2026-07-31 | 11,676,586 | -2.8% | 9.41 | 1,240,232 |
| 2026-07-15 | 12,015,392 | -5.3% | 9.15 | 1,312,513 |
| 2026-06-30 | 12,687,615 | -5.6% | 4.71 | 2,692,053 |
| 2026-06-15 | 13,437,418 | -4.8% | 6.39 | 2,103,228 |
| 2026-05-29 | 14,122,154 | +0.8% | 8.16 | 1,729,763 |
| 2026-05-15 | 14,008,379 | -1.5% | 4.48 | 3,128,402 |
| 2026-04-30 | 14,216,705 | +11.7% | 7.20 | 1,974,002 |
| 2026-04-15 | 12,725,544 | -5.4% | 3.73 | 3,410,312 |
| 2026-03-31 | 13,446,405 | +0.5% | 11.01 | 1,221,504 |
| 2026-03-13 | 13,383,909 | -5.6% | 10.64 | 1,258,175 |
| 2026-02-27 | 14,180,739 | -6.8% | 9.69 | 1,463,647 |
| 2026-02-13 | 15,217,326 | +5.0% | 10.77 | 1,413,273 |
| 2026-01-30 | 14,491,659 | -5.7% | 8.67 | 1,671,645 |
| 2026-01-15 | 15,365,503 | +7.3% | 3.45 | 4,452,964 |
| 2025-12-31 | 14,312,827 | +17.4% | 7.31 | 1,957,813 |
| 2025-12-15 | 12,196,281 | +11.2% | 8.06 | 1,513,672 |
| 2025-11-28 | 10,969,722 | +5.9% | 8.35 | 1,313,897 |
| 2025-11-14 | 10,355,808 | -4.8% | 4.81 | 2,152,492 |
| 2025-10-31 | 10,879,506 | -8.1% | 4.98 | 2,183,311 |
| 2025-10-15 | 11,840,340 | +5.3% | 7.26 | 1,631,893 |
| 2025-09-30 | 11,241,968 | -8.7% | 5.32 | 2,111,348 |
import finzdata as yf
yf.Ticker("TVTX").short_interest # every report since 2017
yf.Client().short_interest(["TVTX"], start="2018-01-01")Healthcare short interest · TVTX price history · Who owns TVTX · All short interest